Hepatitis C Virus Diagnosis and the Holy Grail

Hdl Handle:
http://hdl.handle.net/10144/619174
Title:
Hepatitis C Virus Diagnosis and the Holy Grail
Authors:
Applegate, TL; Fajardo, E; Sacks, JA
Journal:
Infectious Disease Clinics of North America
Abstract:
The world has embraced the call for global elimination of hepatitis C virus by 2030. The unprecedented speed of therapeutic development and increased access to direct-acting antivirals has made elimination a possibility. We must screen hundreds of millions of people to diagnose and treat those currently infected. Global access to hepatitis C virus diagnostics will be a keystone to success. Key challenges must be overcome and systems optimized to ensure widespread access to existing diagnostics. Although promising technologies may soon transform the landscape, innovative strategies are needed to stimulate investment and accelerate the development of point-of-care hepatitis C virus diagnostics.
Publisher:
Elsevier
Issue Date:
Jun-2018
URI:
http://hdl.handle.net/10144/619174
DOI:
10.1016/j.idc.2018.02.010
PubMed ID:
29778264
Submitted date:
2018-06-04
Language:
en
ISSN:
1557-9824
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorApplegate, TLen
dc.contributor.authorFajardo, Een
dc.contributor.authorSacks, JAen
dc.date.accessioned2018-06-12T14:56:53Z-
dc.date.available2018-06-12T14:56:53Z-
dc.date.issued2018-06-
dc.date.submitted2018-06-04-
dc.identifier.citationHepatitis C Virus Diagnosis and the Holy Grail. 2018, 32 (2):425-445 Infect. Dis. Clin. North Am.en
dc.identifier.issn1557-9824-
dc.identifier.pmid29778264-
dc.identifier.doi10.1016/j.idc.2018.02.010-
dc.identifier.urihttp://hdl.handle.net/10144/619174-
dc.description.abstractThe world has embraced the call for global elimination of hepatitis C virus by 2030. The unprecedented speed of therapeutic development and increased access to direct-acting antivirals has made elimination a possibility. We must screen hundreds of millions of people to diagnose and treat those currently infected. Global access to hepatitis C virus diagnostics will be a keystone to success. Key challenges must be overcome and systems optimized to ensure widespread access to existing diagnostics. Although promising technologies may soon transform the landscape, innovative strategies are needed to stimulate investment and accelerate the development of point-of-care hepatitis C virus diagnostics.en
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to Infectious Disease Clinics of North Americaen
dc.titleHepatitis C Virus Diagnosis and the Holy Grailen
dc.identifier.journalInfectious Disease Clinics of North Americaen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.